Abstract
PURPOSE: To describe the results of an intravitreal dexamethasone implant in managing autoimmune retinopathy (AIR). METHODS: Two patients affected by AIR underwent intravitreal dexamethasone implantation and were followed by ocular coherence tomography, visual fields, and electroretinography. RESULTS: The patients showed an interruption of the functional losses and remained stable with semestral injections. CONCLUSION: AIR is a complex condition with no standard treatment. The use of dexamethasone could be a valid option.